Genmab A/S
LSE:0MGB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genmab A/S
LSE:0MGB
|
DK |
|
Siemens Healthineers AG
LSE:0PMJ
|
DE |
|
Deluxe Corp
NYSE:DLX
|
US |
|
Retail Estates NV
XBRU:RET
|
BE |
|
Rockhopper Exploration PLC
LSE:RKH
|
UK |
|
G
|
Greenland Resources Inc
OTC:GRLRF
|
CA |
|
M
|
Mogo Inc
TSX:ORIO
|
CA |
Wall St Price Targets
0MGB Price Targets Summary
Genmab A/S
According to Wall Street analysts, the average 1-year price target for 0MGB is 2 344.4 DKK with a low forecast of 1 313.7 DKK and a high forecast of 3 122.27 DKK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0MGB's stock price target?
Price Target
2 344.4
DKK
According to Wall Street analysts, the average 1-year price target for 0MGB is 2 344.4 DKK with a low forecast of 1 313.7 DKK and a high forecast of 3 122.27 DKK.
What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Genmab A/S?
Projected CAGR
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%
The compound annual growth rate for Operating Income over the next 8 years is 10%.
What is the Pre-Tax Income forecast for Genmab A/S?
Projected CAGR
16%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 16%.
What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%
The compound annual growth rate for Net Income over the next 8 years is 12%.
